3Madrid AH, Matin IM, Cervantes CE, et all Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers [ J ]. J Renin Angiotensin Aldosterone Syst, 2004, 5:114- 120.
4Madrid AH, Peng J, Zamora J,et al. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases : meta-analysis of randomized controlled clinical trials [ J ]. Pacing Clin Electrophysial, 2004, 27 :1405 - 1410.
5Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications [ J ]. Arch Intern Med , 1995, 155:469 - 473.
6Ruigomez A, Jollan-sson S, Wallander MA, et al. Incidenceof chronic atrial fibrillation in general practice and its treatment pattern [ J ]. J Clin Epidemiol, 2002, 55: 358- 363.
7Go AS: Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study[ J]. JAMA, 2001, 285:2370 - 2375.
8Kannel WB, Abbott RD,Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med ,1982, 306:1018 - 1022.
9Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study[J]. JAMA, 1994, 271:840 - 844.
10Kato'T,-Yamashita T, Sagara K, et al. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study[J]. Circ J, 200d, 68:568-572.
6Task Force of the Europen Society of Cardiology and the North American Society of Pacing and Electrophysiology.Heart rate variability,standards of measurement,physiological interpretation clinical use[J].Circulation,1996,93:1043.
7Pokushalov E, Romanov A, Corbucci G, et al. A randomized comparison of pulmonary vein isolation with versus without con- comitant renal artery denervation in patients with refractorysymptomatic atrial fibrillation and resistant hypertension [J]. Journal of the American College of Cardiology, 2012, 60(13): 1163-1170.
8Ba nerjee A, Fauchier L, Vourch P, et al. Renal impairment and ischemic stroke risk assessment in patients with atrial fibril- lation: The loire valley atrial fibrillation proiect [J]. Journal of the American College of Cardiology, 2013, 61(20) : 2079-2087.
